Table 2 The effects of fasting on tumor progression during chemotherapy. Period = length of fasting; MC = multiple cycles of fasting; Y = yes; N = no.

Cell lines

24 h

BxPC-3, MiaPaca-2 and Panc-1

Pancreatic

Y

[9]

24 h

SKBR3, BT474, HCT116, HCC827, H3122

Colorectal, breast

Y

Y

[80]

24 h

U251, LN229, and A172

Glioblastoma

Y

Y

[11]

24 h

LN229, SH-SY5Y

Glioma, neuroblastoma

Y

Y

[81]

48 h

CT26

Colon

Y

[10]

Animal

72 h

Male BALB/c mice

Colon

Y

[12]

24 h

Female Nu/Nu mice

Pancreatic

Y

[9]

48 h (MC)

Female BALB/c mice

Colon

Y

[10]

72 h

LID mice

Melanoma

Y

Y

[73]

48 h (MC)

BALB/c and C57BL/6 mice

Neuroblastoma, breast, ovarian

Y

Y

[6]

48 h (MC)

Female BALB/c athymic mice

Colorectal, breast

Y

Y

[80]

24–48 h (MC)

Male C57BL/6 N mice

Glioblastoma

Y

Y

[11]

24 h

Canine

Lymphoma

Y

[82]